Jallal Bahija insider trades
Jallal Bahija has filed 10 Form 4s with the SEC that we hold, for Elevance Health, Inc. (ELV) (Director), Immunocore Holdings plc (IMCR) (CHIEF EXECUTIVE OFFICER, Director), ArriVent BioPharma, Inc. (AVBP) (Director) and Guardant Health, Inc. (GH) (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $371.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($371.2K). The largest single trade was a sale of 11,474 shares of Immunocore Holdings plc worth $371.2K, dated 2026-02-18. The first filing on our record is dated 2022-05-20 and the latest 2026-05-15.
Elevance Health, Inc. (ELV)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Immunocore Holdings plc (IMCR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-02-18 | S, sale reported on Form 4 | 11,474 | $371.2K | 2026-02-19 | SEC |
ArriVent BioPharma, Inc. (AVBP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Guardant Health, Inc. (GH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1730038) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
